NeuClone is a biotech company that is developing recombinant CHO cell lines for the biopharmaceutical and biomanufacturing industries.

NeuClone's cell lines produce recombinant proteins both authentic and generic versions of biological drugs for which patents have expired.

The Company's core expertise is the generation of stable Chinese Hamster Ovary (CHO) cell lines used in the commercial production of therapeutic proteins.

NeuClone is a global provider of industrial cell lines for the manufacturer of recombinant proteins including biogenerics.